(Q38150651)

29 August 2017

Cancer genomics identifies disrupted epigenetic genes (English)

1 reference

29 August 2017

0 references

2

1 reference

29 August 2017

Laia Simó-Riudalbas

1

1 reference

29 August 2017

9 October 2013

1 reference

29 August 2017

1 reference

29 August 2017

133

1 reference

29 August 2017

713-725

1 reference

29 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s00439-013-1373-5

29 August 2017

0 references

cites work

High-resolution profiling of histone methylations in the human genome

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Nucleosome-interacting proteins regulated by DNA and histone methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

An operational definition of epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Genomic maps and comparative analysis of histone modifications in human and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

DNA methylation patterns and epigenetic memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Anticancer activities of histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Inhibition of BET bromodomain targets genetically diverse glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

The biology of chromatin remodeling complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

High sensitivity mapping of methylated cytosines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Histone modifiers in cancer: friends or foes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

The ING gene family in the regulation of cell growth and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Mutations and deletions of ARID1A in breast tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Causes and consequences of microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Cancer epigenetics: from mechanism to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Mutation in TET2 in myeloid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

MethyLight: a high-throughput assay to measure DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Cancer epigenomics: DNA methylomes and histone-modification maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Non-coding RNAs in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

How epigenetics integrates nuclear functions. Workshop on epigenetics and chromatin: transcriptional regulation and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Epigenetic regulation of miRNAs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Insights from genomic profiling of transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

The history of cancer epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Selective inhibition of BET bromodomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Most mammalian mRNAs are conserved targets of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Methylome profiling of cancer cells by amplification of inter-methylated sites (AIMS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Insertion/deletion polymorphisms in the promoter region of BRM contribute to risk of hepatocellular carcinoma in Chinese populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Lessons from the cancer genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Intronic RNAs mediate EZH2 regulation of epigenetic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Distinct DNA methylomes of newborns and centenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

DICER1 mutations in familial pleuropulmonary blastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

MicroRNA signatures in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Genome-wide mapping of in vivo protein-DNA interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Genomic DNA methylation: the mark and its mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Chromatin modifications and their function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

MLL translocations, histone modifications and leukaemia stem-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Initial sequencing and analysis of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Acquired mutations in TET2 are common in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

The language of histone crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

DNMT3A Mutations in Acute Myeloid Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Targeted mutation of the DNA methyltransferase gene results in embryonic lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

The role of chromatin during transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Loss of SNF5 expression correlates with poor patient survival in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

The Polycomb complex PRC2 and its mark in life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

RETRACTED: A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Immunoprecipitation of native chromatin: NChIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

The genetic landscape of the childhood cancer medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Inactivating mutations of acetyltransferase genes in B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Genome-wide views of chromatin structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Co-evolution of X-chromosome inactivation and imprinting in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Massive parallel DNA pyrosequencing analysis of the tumor suppressor BRG1/SMARCA4 in lung primary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Cancer epigenetics reaches mainstream oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Sirtuins: critical regulators at the crossroads between cancer and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

From DNA sequence to transcriptional behaviour: a quantitative approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Global histone modification patterns predict risk of prostate cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

DNMT3B gene amplification predicts resistance to DNA demethylating drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Towards cracking the epigenetic code using a combination of high-throughput epigenomics and quantitative mass spectrometry-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Evaluation of a potential epigenetic biomarker by quantitative methyl-single nucleotide polymorphism analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Switching from repression to activation: microRNAs can up-regulate translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

The Sequence of the Human Genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Transcription of IAP endogenous retroviruses is constrained by cytosine methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Combinatorial patterns of histone acetylations and methylations in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Long noncoding RNAs: functional surprises from the RNA world

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Promoter hypermethylation of ARID1A gene is responsible for its low mRNA expression in many invasive breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Recognition of methylated DNA through methyl-CpG binding domain proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-013-1373-5

Genome-wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancer.

21 January 2018

1 reference

12 December 2020

Methylation profiling of CpG islands in human breast cancer cells

1 reference

12 December 2020

BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines

1 reference

12 December 2020

DNA methylation: a profile of methods and applications

1 reference

12 December 2020

DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset

1 reference

12 December 2020

An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes

1 reference

12 December 2020

A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer.

1 reference

12 December 2020

Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk

1 reference

12 December 2020

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

12 December 2020

Cancer genomics: from discovery science to personalized medicine

1 reference

12 December 2020

10.1007/S00439-013-1373-5

Identifiers

DOI

1 reference

PubMed ID

24104525

Dimensions Publication ID

29 August 2017

0 references

1 reference

PubMed ID

24104525